|Bid||7.07 x 800|
|Ask||7.13 x 1800|
|Day's Range||6.89 - 7.24|
|52 Week Range||5.67 - 11.95|
|Beta (3Y Monthly)||0.30|
|PE Ratio (TTM)||24.30|
|Earnings Date||Feb 25, 2019 - Mar 1, 2019|
|Forward Dividend & Yield||0.08 (1.15%)|
|1y Target Est||15.00|
US unleashed 'toughest sanctions ever' on Iran. Yahoo Finance's Julie Hyman, Adam Shapiro, Andy Serwer and Campus Reform's Cabbot Phillips discuss with former US ambassador to Bahrain Adam Ereli.
Global Cord Blood Corp NYSE:COView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for CO with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CO. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding CO totaled $29 million. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
3Q 19 Added 23,663 New Subscribers Revenues Up 3.7% YoY to RMB254.2 Million ( $37.0 Million ) Operating Income Increased to RMB92.6 Million ( $13.5 Million ) Conference Call to be Held on February 26, ...
Earnings Call Scheduled for 8:00 a.m. ET on February 26, 2019 HONG KONG , Feb. 19, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord ...
HONG KONG , Dec. 6, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic ...
After reading Global Cord Blood Corporation’s (NYSE:CO) latest earnings update (30 June 2018), I found it beneficial to look back at how the company has performed in the past and Read More...
2Q19 Added 22,908 New Subscribers Revenues Up 5.3% YoY to RMB247.1 Million ( $36.0 Million ) Operating Income Up 37.3% YoY to RMB104.8 Million ( $15.3 Million ) ...
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return Read More...
Earnings Call Scheduled for 8:00 a.m. ET on November 28 , 2018 HONG KONG , Nov. 20, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of ...
HONG KONG, Sept. 21, 2018 /PRNewswire/ -- Global Cord Blood Corporation (CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2018 annual general meeting of shareholders at its Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. Hong Kong Time on December 5, 2018 (8:00 a.m. U.S. Eastern Standard Time on December 5, 2018).